STAAR Surgical Company STAA

Full chart Compare
Set alert

Price alert · STAA

All alert types
26.55 USD -0.62 (-2.28%)

Nov 5, 2026, 3:47 PM EST

26.00 Day range 29.57
15.59 52-week range 35.87
YTD
+14.98%
1 year
+5.15%

Revenue & Expenses

Income Tax Benefit → Expenses: $1.81MExpenses → Selling, General & Admin: $188.31MExpenses → Research & Development: $40.05MExpenses → Other Expenses: $36.32MGross Profit → Expenses: $182.42MRevenue → Gross Profit: $182.42MRevenue → Cost of Revenue: $57.02MNet Loss → Expenses: $80.45MIncome Tax Benefit$1.81MGross Profit$182.42MNet Loss$80.45MCost of Revenue$57.02MExpenses$264.68MSelling, General & Admin$188.31MResearch & Development$40.05MOther Expenses$36.32MRevenue$239.44M

Latest period ending Jan 2, 2026 · select a line to chart its full history

STAA annual income statement
Fiscal yearFY 2025 Jan 2, 2026FY 2024 Dec 27, 2024FY 2023 Dec 29, 2023FY 2022 Dec 30, 2022FY 2021 Dec 31, 2021
239.44M313.90M322.42M284.39M230.47M
182.42M239.58M252.65M223.38M178.64M
-91.71M-12.61M28.10M43.80M33.34M
-80.45M-20.21M21.35M39.66M27.51M
-1.62-0.410.430.800.56
STAA annual balance sheet
Fiscal yearFY 2025 Jan 2, 2026FY 2024 Dec 27, 2024FY 2023 Dec 29, 2023FY 2022 Dec 30, 2022FY 2021 Dec 31, 2021
153.15M144.16M183.04M86.48M199.71M
451.68M509.52M488.69M418.82M345.78M
107.49M112.19M102.74M82.71M87.22M
38.35M38.74M35.83M31.04M32.06M
344.18M397.33M385.95M336.11M258.56M
STAA annual cash flow
Fiscal yearFY 2025 Jan 2, 2026FY 2024 Dec 27, 2024FY 2023 Dec 29, 2023FY 2022 Dec 30, 2022FY 2021 Dec 31, 2021
-34.23M15.72M14.59M35.72M43.96M
46.34M-59.22M74.35M-156.38M-13.64M
-4.55M5.72M7.42M8.30M17.79M
-5.82M-23.39M-18.19M-18.11M-13.64M
8.99M-38.88M96.56M-113.23M47.25M